{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:53:42Z","timestamp":1792641222665,"version":"4.5.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Genentech and Jannsen Pharmaceutical"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,31]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Up to 20% of patients with antineutrophil cytoplasmic antibody\u2013associated vasculitis (AAV) and kidney involvement progress to end-stage kidney disease (ESKD) despite therapy. The role of monoclonal gammopathy (MG) in disease progression in patients with AAV is not well understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective study to identify patients diagnosed with AAV and renal involvement who had undergone monoclonal protein testing between November 1999 and December 2023. A total of 167 patients were included in the renal survival analysis and were categorized into monoclonal positive (n\u00a0=\u00a034) and monoclonal negative (n\u00a0=\u00a0133) groups. For the mortality analysis, we expanded the cohort to include an additional 26 patients who were dialysis-dependent at baseline and remained on dialysis throughout follow-up, resulting in a total of 193 patients. We performed multivariate Cox analysis to identify predictors of adverse renal events [&amp;gt;40% decline in estimated glomerular filtration rate (eGFR) or ESKD (eGFR &amp;lt;15 mL\/min\/1.73 m\u00b2, need for dialysis or transplantation)] and mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Median age of the cohort was 68 (58.5\u201374.5) years, with 50.8% males, 65.8% MPO positive, and 64.6% receiving rituximab as induction therapy. After adjusting for baseline proteinuria, sclerotic Berden class and induction therapy, MG was associated with adverse renal events [hazard ratio (HR) 3.29 (95% confidence interval 1.12\u20139.68), P\u00a0=\u00a0.03]. MG at baseline was not associated with mortality [HR 1.65 (0.87\u20133.12), P\u00a0=\u00a0.12], however patients with persistent MG at 6 months had higher mortality compared with those without MG or those whose MG was not sustained [HR 3.95 (1.10\u201314.21), P\u00a0=\u00a0.035].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with AAV and renal involvement who have MG are at significantly increased risk of adverse renal events even after adjusting for factors such as eGFR and degree of chronicity (known predictors of poor renal outcome). The exact mechanism by which MG portends poor outcomes is poorly understood, and additional research is required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ndt\/gfaf195","type":"journal-article","created":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:49:01Z","timestamp":1758368941000},"page":"692-702","source":"Crossref","is-referenced-by-count":2,"title":["Monoclonal gammopathy associates with kidney failure in ANCA-associated vasculitis"],"prefix":"10.1093","volume":"41","author":[{"given":"Poemlarp","family":"Mekraksakit","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension , Mayo Clinic, Rochester, MN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J","family":"Vargas-Brochero","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension , Mayo Clinic, Rochester, MN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilario","family":"Russo","sequence":"additional","affiliation":[{"name":"University of Bari Aldo Moro Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), , Bari ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Buglioni","sequence":"additional","affiliation":[{"name":"Mayo Clinic Department of Laboratory Medicine and Pathology, , Rochester, MN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Inacio","sequence":"additional","affiliation":[{"name":"Setubal Hospital Center Department of Nephrology, , Set\u00fabal ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5500-4293","authenticated-orcid":false,"given":"Patricia","family":"Domingues","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension , Mayo Clinic, Rochester, MN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeshwanter","family":"Radhakrishnan","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension , Mayo Clinic, Rochester, MN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladan","family":"Zand","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension , Mayo Clinic, Rochester, MN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"key":"2026033111020460200_bib1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2026033111020460200_bib2","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1136\/annrheumdis-2013-203255","article-title":"Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?","volume":"72","author":"Millet","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2026033111020460200_bib3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1053\/j.ajkd.2019.04.031","article-title":"ANCA-associated vasculitis: core curriculum 2020","volume":"75","author":"Geetha","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"2026033111020460200_bib4","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/ndt\/gfae069.1257","article-title":"Long-term outcome of kidney function in patients with ANCA-associated vasculitis","volume":"39","author":"Alamo","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2026033111020460200_bib5","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.kint.2018.07.020","article-title":"Development and validation of a renal risk score in ANCA-associated glomerulonephritis","volume":"94","author":"Brix","year":"2018","journal-title":"Kidney Int"},{"key":"2026033111020460200_bib6","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1182\/blood-2012-07-445304","article-title":"Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant","volume":"120","author":"Leung","year":"2012","journal-title":"Blood"},{"key":"2026033111020460200_bib7","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1056\/NEJMra1810907","article-title":"Monoclonal gammopathy of renal significance","volume":"384","author":"Leung","year":"2021","journal-title":"N Engl J Med"},{"key":"2026033111020460200_bib8","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.kint.2016.09.045","article-title":"Thrombotic microangiopathy associated with monoclonal gammopathy","volume":"91","author":"Ravindran","year":"2017","journal-title":"Kidney Int"},{"key":"2026033111020460200_bib9","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1084\/jem.175.4.939","article-title":"Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis","volume":"175","author":"Meri","year":"1992","journal-title":"J Exp Med"},{"key":"2026033111020460200_bib10","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.3389\/fimmu.2018.02260","article-title":"Both monoclonal and polyclonal immunoglobulin contingents mediate complement activation in monoclonal gammopathy associated-C3","volume":"9","author":"Chauvet","year":"2018","journal-title":"Front Immunol"},{"key":"2026033111020460200_bib11","doi-asserted-by":"publisher","first-page":"4590","DOI":"10.4049\/jimmunol.163.8.4590","article-title":"Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H","volume":"163","author":"Jokiranta","year":"1999","journal-title":"J Immunol"},{"key":"2026033111020460200_bib12","doi-asserted-by":"publisher","first-page":"e12870","DOI":"10.1111\/sji.12870","article-title":"NETs analysed by novel calprotectin-based assays in blood donors and patients with multiple myeloma or rheumatoid arthritis: a pilot study","volume":"91","author":"Fagerhol","year":"2020","journal-title":"Scand J Immunol"},{"key":"2026033111020460200_bib13","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.3390\/cancers12113424","article-title":"Quantification of citrullinated histone H3 bound DNA for detection of neutrophil extracellular traps","volume":"12","author":"Li","year":"2020","journal-title":"Cancers"},{"key":"2026033111020460200_bib14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nm.4294","article-title":"An emerging role for neutrophil extracellular traps in noninfectious disease","volume":"23","author":"Jorch","year":"2017","journal-title":"Nat Med"},{"key":"2026033111020460200_bib15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/ckj\/sft044","article-title":"Monoclonal gammopathy-associated pauci-immune extracapillary-proliferative glomerulonephritis successfully treated with bortezomib","volume":"6","author":"Grundmann","year":"2013","journal-title":"Clin Kidney J"},{"key":"2026033111020460200_bib16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1053\/j.ajkd.2010.08.011","article-title":"Rare association of chronic lymphocytic leukemia\/small lymphocytic lymphoma, ANCAs, and pauci-immune crescentic glomerulonephritis","volume":"57","author":"Henriksen","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"2026033111020460200_bib17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000432394","article-title":"Antineutrophil cytoplasmic antibodies-negative pauci-immune crescentic glomerulonephritis associated with multiple myeloma","volume":"5","author":"Anaele","year":"2015","journal-title":"Case Rep Nephrol Dial"},{"key":"2026033111020460200_bib18","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1007\/s11255-023-03579-0","article-title":"The clinical value of monoclonal protein in ANCA-associated vasculitis with renal involvement","volume":"55","author":"Wang","year":"2023","journal-title":"Int Urol Nephrol"},{"key":"2026033111020460200_bib19","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1056\/NEJMoa1803537","article-title":"Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis","volume":"382","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"key":"2026033111020460200_bib20","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.kint.2017.01.002","article-title":"A proposal for standardized grading of chronic changes in native kidney biopsy specimens","volume":"91","author":"Sethi","year":"2017","journal-title":"Kidney Int"},{"key":"2026033111020460200_bib21","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1681\/ASN.2010050477","article-title":"Histopathologic classification of ANCA-associated glomerulonephritis","volume":"21","author":"Berden","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"2026033111020460200_bib22","doi-asserted-by":"publisher","first-page":"i13","DOI":"10.1093\/ndt\/gfad063a_5127","article-title":"#5127 Combined activity and chronicity score for prognostic assessment in anca-associated vasculitis with glomerulonephritis","volume":"38","author":"Moura","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2026033111020460200_bib23","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.ekir.2024.11.019","article-title":"\u201cNormal\u201d glomerular score correlates with outcomes in antineutrophil cytoplasmic autoantibody-associated vasculitis with glomerulonephritis","volume":"10","author":"Casal Moura","year":"2025","journal-title":"Kidney Int Rep"},{"key":"2026033111020460200_bib24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41408-021-00408-4","article-title":"Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an international myeloma working group mass spectrometry committee report","volume":"11","author":"Murray","year":"2021","journal-title":"Blood Cancer J"},{"key":"2026033111020460200_bib25","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1053\/j.ajkd.2019.04.029","article-title":"Dysproteinemia and the kidney: core curriculum 2019","volume":"74","author":"Hogan","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"2026033111020460200_bib26","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/clinchem\/48.9.1437","article-title":"Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains","volume":"48","author":"Katzmann","year":"2002","journal-title":"Clin Chem"},{"key":"2026033111020460200_bib27","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.2215\/CJN.02290508","article-title":"Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease","volume":"3","author":"Hutchison","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026033111020460200_bib28","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"key":"2026033111020460200_bib29","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.mayocp.2021.07.024","article-title":"Detection of plasma cell disorders by mass spectrometry: a comprehensive review of 19,523 cases","volume":"97","author":"Dasari","year":"2022","journal-title":"Mayo Clin Proc"},{"key":"2026033111020460200_bib30","first-page":"153","article-title":"Anti-neutrophil cytoplasm antibodies in patients with monoclonal gammopathies","volume":"32","author":"Esnault","year":"1990","journal-title":"J Clin Lab Immunol"},{"key":"2026033111020460200_bib31","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3389\/fimmu.2017.01347","article-title":"Pro-inflammatory state in monoclonal gammopathy of undetermined significance and in multiple myeloma is characterized by low sialylation of pathogen-specific and other monoclonal immunoglobulins","volume":"8","author":"Bosseboeuf","year":"2017","journal-title":"Front Immunol"},{"key":"2026033111020460200_bib32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/cei.13515","article-title":"The rise of complement in ANCA-associated vasculitis: from marginal player to target of modern therapy","volume":"202","author":"Trivioli","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"2026033111020460200_bib33","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s13730-022-00703-4","article-title":"Emergence of proteinase 3-antineutrophil cytoplasmic antibody-associated glomerulonephritis with mesangial immune deposition during the clinical course of IgG \u03bb monoclonal gammopathy of uncertain significance","volume":"11","author":"Ueno","year":"2022","journal-title":"CEN Case Rep"},{"key":"2026033111020460200_bib34","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.2215\/CJN.04800516","article-title":"Prognostic value of histologic classification of ANCA-associated glomerulonephritis","volume":"11","author":"Bj\u00f8rneklett","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026033111020460200_bib35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1471-2369-14-125","article-title":"Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis","volume":"14","author":"Iwakiri","year":"2013","journal-title":"BMC Nephrol"},{"key":"2026033111020460200_bib36","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1007\/s10067-016-3195-z","article-title":"Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement","volume":"35","author":"C\u00f3rdova-S\u00e1nchez","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2026033111020460200_bib37","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/ndt\/gfh563","article-title":"Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis","volume":"20","author":"Neumann","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"2026033111020460200_bib38","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1080\/0886022X.2018.1487865","article-title":"Clinical and pathologic characteristics of pauci-immune anti-myeloperoxidase antibody associated glomerulonephritis with nephrotic range proteinuria","volume":"40","author":"Xu","year":"2018","journal-title":"Ren Fail"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfaf195\/64345860\/gfaf195.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/4\/692\/64345860\/gfaf195.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/4\/692\/64345860\/gfaf195.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:02:06Z","timestamp":1774969326000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/41\/4\/692\/8261535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,9,22]]},"published-print":{"date-parts":[[2026,3,31]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfaf195","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2025,9,22]]}}}